Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold... Tender

Procurement Summary

Country: USA

Summary: Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus

Deadline: 27 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 124926595

Document Ref. No.: W81K0225QA100

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

The Medical Readiness Contracting Office - Pacific, Joint Base Lewis McChord Health Contracting Branch is issuing this sources sought notice for informational purposes only. The notice is a means of conducting market research to identify industry-s capabilities.

The Madigan Army Medical Center (MAMC) Department of Pathology requires reagents for the detection of Mycobacterium tuberculosis (TB), a QuantiFERON TB Gold-Plus assay.

This sources sought notice is not a solicitation for quotations, proposals nor invitation for bids. Any information submitted by respondents to this notice is strictly voluntary and will not be compensated. Telephonic inquiries will not be accepted or acknowledged. The Government will not evaluate the information received nor provide comments or feedback.

Your response to the information requested will assist the Government in determining the appropriate acquisition method. Businesses of all sizes are encouraged to respond; however, each respondent must clearly identify their business size in their capabilities and qualifications statement. A determination by the Government not to compete this proposed effort based upon responses to this notice is solely within the discretion of the Government. The Government is not obligated to issue a solicitation nor award a contract under this announcement. If a solicitation is released, it will be synopsized on the Government-Wide Point of Entry (GPE). It is the responsibility of potential offerors to monitor the GPE for additional information pertaining to this requirement.

Project Background

The MAMC Department of Pathology currently uses QuantiFERON TB Gold-Plus assay to detect TB using the LIAISON xL System. Qiagen QFT Gold Plus is a testing method that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB). Qiagen is the only FDA approved source available for in house latent TB testing from blood samples using InterFeron ...
Active Contract Opportunity
Notice ID : W81K0225QA100
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE ARMY
Major Command : US ARMY MEDICAL COMMAND
Office: W40M MRCO PACIFIC
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Aug 21, 2025 06:11 pm EDT
Original Response Date: Aug 27, 2025 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Sep 11, 2025
Initiative: None

Classification
Original Set Aside: No Set aside used
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Tacoma, WA USA

Documents

 Tender Notice